IVF system fails to pass the pub test, minister says
State and territory health ministers met with their federal counterpart on Friday, where it was agreed that a rapid nationwide review would begin to consider establishing an independent accreditation body.
It comes after Monash IVF revealed staff had transferred the wrong embryo to a woman at a Melbourne clinic last week, following a similar blunder involving a separate Monash patient in Brisbane.
Victorian Health Minister Mary-Anne Thomas said she hoped the establishment of an independent body could occur immediately, but claimed it was met with pushback from Queensland.
"We got to move quickly," she told reporters.
"It's concerning ... there may well be more errors that we don't know about. And that is because the body that currently accredits fertility care providers is made up of fertility care providers.
"That's why I find Queensland's position so perplexing."
A spokesman for Queensland Health Minister Tim Nicholls said the minister had "advocated for an informed understanding" of the accreditation and regulation framework.
"Health ministers decided that Queensland would lead work to understand the issues better and to ensure a strategy would be well informed," the spokesman said.
The three-month review will consider whether the state regulatory schemes are fit for purpose when it comes to safety and quality.
The IVF industry is primarily regulated by states and territories.
Clinics must be licensed to operate by the Reproductive Technology Accreditation Committee.Ms Thomas said the main issue for her was how fertility care was accredited.
"It simply doesn't pass the pub test that the people that provide the service are also the ones that determine who provides the service," she said.
"We have work to do there."
Federal Health Minister Mark Butler, who used IVF to welcome his third child, described the two recent embryo mix-ups as "frankly shocking".
"As governments, we've got a responsibility to see whether there are better levels of regulation that should be put in place, and to inject some confidence back into a system that delivers such joy to so many thousands of families every year," he told ABC Radio.
Monash IVF chief executive Michael Knaap resigned on Thursday after it was revealed staff at a Melbourne laboratory gave a patient one of her embryos, instead of one from her partner as intended.
An investigation is under way into how it happened.
The company, which has a presence across Australia, apologised to the couple, while the Victorian Health Regulator has also launched an investigation.
Monash revealed in April that a woman at a Brisbane facility was incorrectly impregnated with another patient's embryo, which was blamed on "human error".
The mistake was picked up after the child was born when the birth parents asked for their remaining embryos to be transferred elsewhere and an additional embryo was unexpectedly found in storage.
Former Monash director Gab Kovacs, who was involved with developing earlier IVF guidelines, told AAP the mix-up was a "very rare occurrence".
"However, with 100,000 cycles of IVF in Australia, even with this occurring very, very rarely, it is inevitable that this will happen," Mr Kovacs said.
"It is due to human error and this cannot be eliminated.
"The two incidents happened in two separate clinics, 2000km apart ... (involving) different personnel, different lab managers."
About 20,000 babies conceived by IVF are born in Australia each year.
Australia's IVF accreditation system fails to pass the pub test, a government minister has said, as discussions continue following multiple embryo mix-ups at one of the nation's largest fertility providers.
State and territory health ministers met with their federal counterpart on Friday, where it was agreed that a rapid nationwide review would begin to consider establishing an independent accreditation body.
It comes after Monash IVF revealed staff had transferred the wrong embryo to a woman at a Melbourne clinic last week, following a similar blunder involving a separate Monash patient in Brisbane.
Victorian Health Minister Mary-Anne Thomas said she hoped the establishment of an independent body could occur immediately, but claimed it was met with pushback from Queensland.
"We got to move quickly," she told reporters.
"It's concerning ... there may well be more errors that we don't know about. And that is because the body that currently accredits fertility care providers is made up of fertility care providers.
"That's why I find Queensland's position so perplexing."
A spokesman for Queensland Health Minister Tim Nicholls said the minister had "advocated for an informed understanding" of the accreditation and regulation framework.
"Health ministers decided that Queensland would lead work to understand the issues better and to ensure a strategy would be well informed," the spokesman said.
The three-month review will consider whether the state regulatory schemes are fit for purpose when it comes to safety and quality.
The IVF industry is primarily regulated by states and territories.
Clinics must be licensed to operate by the Reproductive Technology Accreditation Committee.Ms Thomas said the main issue for her was how fertility care was accredited.
"It simply doesn't pass the pub test that the people that provide the service are also the ones that determine who provides the service," she said.
"We have work to do there."
Federal Health Minister Mark Butler, who used IVF to welcome his third child, described the two recent embryo mix-ups as "frankly shocking".
"As governments, we've got a responsibility to see whether there are better levels of regulation that should be put in place, and to inject some confidence back into a system that delivers such joy to so many thousands of families every year," he told ABC Radio.
Monash IVF chief executive Michael Knaap resigned on Thursday after it was revealed staff at a Melbourne laboratory gave a patient one of her embryos, instead of one from her partner as intended.
An investigation is under way into how it happened.
The company, which has a presence across Australia, apologised to the couple, while the Victorian Health Regulator has also launched an investigation.
Monash revealed in April that a woman at a Brisbane facility was incorrectly impregnated with another patient's embryo, which was blamed on "human error".
The mistake was picked up after the child was born when the birth parents asked for their remaining embryos to be transferred elsewhere and an additional embryo was unexpectedly found in storage.
Former Monash director Gab Kovacs, who was involved with developing earlier IVF guidelines, told AAP the mix-up was a "very rare occurrence".
"However, with 100,000 cycles of IVF in Australia, even with this occurring very, very rarely, it is inevitable that this will happen," Mr Kovacs said.
"It is due to human error and this cannot be eliminated.
"The two incidents happened in two separate clinics, 2000km apart ... (involving) different personnel, different lab managers."
About 20,000 babies conceived by IVF are born in Australia each year.
Australia's IVF accreditation system fails to pass the pub test, a government minister has said, as discussions continue following multiple embryo mix-ups at one of the nation's largest fertility providers.
State and territory health ministers met with their federal counterpart on Friday, where it was agreed that a rapid nationwide review would begin to consider establishing an independent accreditation body.
It comes after Monash IVF revealed staff had transferred the wrong embryo to a woman at a Melbourne clinic last week, following a similar blunder involving a separate Monash patient in Brisbane.
Victorian Health Minister Mary-Anne Thomas said she hoped the establishment of an independent body could occur immediately, but claimed it was met with pushback from Queensland.
"We got to move quickly," she told reporters.
"It's concerning ... there may well be more errors that we don't know about. And that is because the body that currently accredits fertility care providers is made up of fertility care providers.
"That's why I find Queensland's position so perplexing."
A spokesman for Queensland Health Minister Tim Nicholls said the minister had "advocated for an informed understanding" of the accreditation and regulation framework.
"Health ministers decided that Queensland would lead work to understand the issues better and to ensure a strategy would be well informed," the spokesman said.
The three-month review will consider whether the state regulatory schemes are fit for purpose when it comes to safety and quality.
The IVF industry is primarily regulated by states and territories.
Clinics must be licensed to operate by the Reproductive Technology Accreditation Committee.Ms Thomas said the main issue for her was how fertility care was accredited.
"It simply doesn't pass the pub test that the people that provide the service are also the ones that determine who provides the service," she said.
"We have work to do there."
Federal Health Minister Mark Butler, who used IVF to welcome his third child, described the two recent embryo mix-ups as "frankly shocking".
"As governments, we've got a responsibility to see whether there are better levels of regulation that should be put in place, and to inject some confidence back into a system that delivers such joy to so many thousands of families every year," he told ABC Radio.
Monash IVF chief executive Michael Knaap resigned on Thursday after it was revealed staff at a Melbourne laboratory gave a patient one of her embryos, instead of one from her partner as intended.
An investigation is under way into how it happened.
The company, which has a presence across Australia, apologised to the couple, while the Victorian Health Regulator has also launched an investigation.
Monash revealed in April that a woman at a Brisbane facility was incorrectly impregnated with another patient's embryo, which was blamed on "human error".
The mistake was picked up after the child was born when the birth parents asked for their remaining embryos to be transferred elsewhere and an additional embryo was unexpectedly found in storage.
Former Monash director Gab Kovacs, who was involved with developing earlier IVF guidelines, told AAP the mix-up was a "very rare occurrence".
"However, with 100,000 cycles of IVF in Australia, even with this occurring very, very rarely, it is inevitable that this will happen," Mr Kovacs said.
"It is due to human error and this cannot be eliminated.
"The two incidents happened in two separate clinics, 2000km apart ... (involving) different personnel, different lab managers."
About 20,000 babies conceived by IVF are born in Australia each year.
Australia's IVF accreditation system fails to pass the pub test, a government minister has said, as discussions continue following multiple embryo mix-ups at one of the nation's largest fertility providers.
State and territory health ministers met with their federal counterpart on Friday, where it was agreed that a rapid nationwide review would begin to consider establishing an independent accreditation body.
It comes after Monash IVF revealed staff had transferred the wrong embryo to a woman at a Melbourne clinic last week, following a similar blunder involving a separate Monash patient in Brisbane.
Victorian Health Minister Mary-Anne Thomas said she hoped the establishment of an independent body could occur immediately, but claimed it was met with pushback from Queensland.
"We got to move quickly," she told reporters.
"It's concerning ... there may well be more errors that we don't know about. And that is because the body that currently accredits fertility care providers is made up of fertility care providers.
"That's why I find Queensland's position so perplexing."
A spokesman for Queensland Health Minister Tim Nicholls said the minister had "advocated for an informed understanding" of the accreditation and regulation framework.
"Health ministers decided that Queensland would lead work to understand the issues better and to ensure a strategy would be well informed," the spokesman said.
The three-month review will consider whether the state regulatory schemes are fit for purpose when it comes to safety and quality.
The IVF industry is primarily regulated by states and territories.
Clinics must be licensed to operate by the Reproductive Technology Accreditation Committee.Ms Thomas said the main issue for her was how fertility care was accredited.
"It simply doesn't pass the pub test that the people that provide the service are also the ones that determine who provides the service," she said.
"We have work to do there."
Federal Health Minister Mark Butler, who used IVF to welcome his third child, described the two recent embryo mix-ups as "frankly shocking".
"As governments, we've got a responsibility to see whether there are better levels of regulation that should be put in place, and to inject some confidence back into a system that delivers such joy to so many thousands of families every year," he told ABC Radio.
Monash IVF chief executive Michael Knaap resigned on Thursday after it was revealed staff at a Melbourne laboratory gave a patient one of her embryos, instead of one from her partner as intended.
An investigation is under way into how it happened.
The company, which has a presence across Australia, apologised to the couple, while the Victorian Health Regulator has also launched an investigation.
Monash revealed in April that a woman at a Brisbane facility was incorrectly impregnated with another patient's embryo, which was blamed on "human error".
The mistake was picked up after the child was born when the birth parents asked for their remaining embryos to be transferred elsewhere and an additional embryo was unexpectedly found in storage.
Former Monash director Gab Kovacs, who was involved with developing earlier IVF guidelines, told AAP the mix-up was a "very rare occurrence".
"However, with 100,000 cycles of IVF in Australia, even with this occurring very, very rarely, it is inevitable that this will happen," Mr Kovacs said.
"It is due to human error and this cannot be eliminated.
"The two incidents happened in two separate clinics, 2000km apart ... (involving) different personnel, different lab managers."
About 20,000 babies conceived by IVF are born in Australia each year.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Age
16 hours ago
- The Age
The ‘fragmented' and costly rules putting our most vulnerable at risk
People caring for children, the elderly, veterans and the disabled would face a national screening system within three years under a plan to protect the country's most vulnerable while slashing expensive red tape that is preventing potential workers from moving into the care economy. Under a proposal from the Productivity Commission, businesses operating in the aged care, the National Disability Insurance Scheme, veterans' care and early childhood sectors would also face a single, national set of quality standards that would make it easier to track poor operators. The federal government is already planning to create a national database of childcare workers after a Victorian man was charged with more than 70 sex offences against eight children aged between five months and two years at a childcare centre in Melbourne. But the commission, in its fifth report before next week's federal government roundtable, argues all areas in which people are required to care for others should be covered by a nationally consistent screening system. More than 2 million people are employed in caring roles, and states and territories have differing regulations. Loading Commissioner Martin Stokie said a single approach that covered both workers and businesses would help protect those in care and reduce red tape, which was hitting productivity in one of the fastest-growing parts of the economy. 'Fragmented regulation across the care sector reduces productivity, heightens the risk of harms, limits access to care and creates unnecessary burdens for care providers,' he said. The commission found 'duplicative, fragmented and inefficient' red tape imposed a large cost on care workers, 79 per cent of whom were women. This can include separate screening processes across different sectors, such as aged care and childcare.
Sydney Morning Herald
16 hours ago
- Sydney Morning Herald
The ‘fragmented' and costly rules putting our most vulnerable at risk
People caring for children, the elderly, veterans and the disabled would face a national screening system within three years under a plan to protect the country's most vulnerable while slashing expensive red tape that is preventing potential workers from moving into the care economy. Under a proposal from the Productivity Commission, businesses operating in the aged care, the National Disability Insurance Scheme, veterans' care and early childhood sectors would also face a single, national set of quality standards that would make it easier to track poor operators. The federal government is already planning to create a national database of childcare workers after a Victorian man was charged with more than 70 sex offences against eight children aged between five months and two years at a childcare centre in Melbourne. But the commission, in its fifth report before next week's federal government roundtable, argues all areas in which people are required to care for others should be covered by a nationally consistent screening system. More than 2 million people are employed in caring roles, and states and territories have differing regulations. Loading Commissioner Martin Stokie said a single approach that covered both workers and businesses would help protect those in care and reduce red tape, which was hitting productivity in one of the fastest-growing parts of the economy. 'Fragmented regulation across the care sector reduces productivity, heightens the risk of harms, limits access to care and creates unnecessary burdens for care providers,' he said. The commission found 'duplicative, fragmented and inefficient' red tape imposed a large cost on care workers, 79 per cent of whom were women. This can include separate screening processes across different sectors, such as aged care and childcare.
The Advertiser
2 days ago
- The Advertiser
'Meteoric rise' in medicinal cannabis prescriptions signals serious review
Cowboy doctors have been put on notice, as telehealth services prescribing unapproved medicinal cannabis to seniors and other vulnerable Australians come under the microscope. Experts have welcomed a move by the government's Therapeutic Goods Administration (TGA) to review the safety and regulatory framework for medicinal cannabis products after increasing public and professional concern. The Australian Medical Association (AMA) said cannabis products are being prescribed at "alarming rates through direct-to-consumer telehealth models". Victorian MP and user of medicinal cannabis, David Ettershank, welcomed the review which includes a callout for public comment, and said it was "long overdue". "There has been a meteoric rise in the use of medicinal cannabis, and that is clear from all the data from the state and federal levels," he told The Senior. "The seniors' market is one of the fastest growing sectors for the medicinal cannabis industry, because of its ability to help with pain, arthritis, stress and sleep management." Read more from The Senior: Mr Ettershank said it's been a "Godsend" to be able to be prescribed approved medicinal cannabis to treat his auto-immune condition Polymyalgia Rheumatica, and ongoing chronic back pain from an injury, though admits it's not a "miracle cure for all ailments". The Senior understands only two medicinal cannabis products have been approved by the TGA, meaning many other products are accessed through the unapproved goods scheme. "Telehealth is an important mechanism to improve access to health services - but these direct-to-consumer, single-issue models lack clear referral pathways or a feedback loop to GPs and as the TGA has acknowledged, this requires much broader consideration by government," said AMA President Dr Danielle McMullen. "We are seeing increasing reports of patient harm from cannabis, including psychosis, so this current surge in prescriptions is highly concerning ...Clearly, the health landscape has changed dramatically in Australia, so it is vital we look at our regulatory settings and find out what needs to be done to address any gaps." Product-specific telehealth services are one of three key issues raised by the TGA. Other key issues include the safety risks of the products and whether there are appropriate regulations oversight of unapproved medicinal cannabis products being accessed via the Special Access Scheme and Authorised Prescriber Scheme. Like every industry, Mr Ettershank said, there will always be people who do the wrong thing for greed or act improperly, though from his own experience he has found practitioners take their responsibilities very seriously. "It's a relatively new industry, having only been around for 10 years, and it is appropriate that we pause occasionally to reflect on what is happening," he said. "I'm concerned that the scope of their consultation is limited, and it is not an inquiry by multiple agencies .... I'd like to see a holistic approach to regulation, reform, safety and quality in the medicinal cannabis sector, but we look forward to participating in the consultation." Further details on the consultation can be found at For enquiries relating to this public consultation, please email MedicinalCannabisReforms@ The closing date for this consultation is 23.59 AEST on October 7 2025. All submissions received by the deadline, will be considered by the TGA. Cowboy doctors have been put on notice, as telehealth services prescribing unapproved medicinal cannabis to seniors and other vulnerable Australians come under the microscope. Experts have welcomed a move by the government's Therapeutic Goods Administration (TGA) to review the safety and regulatory framework for medicinal cannabis products after increasing public and professional concern. The Australian Medical Association (AMA) said cannabis products are being prescribed at "alarming rates through direct-to-consumer telehealth models". Victorian MP and user of medicinal cannabis, David Ettershank, welcomed the review which includes a callout for public comment, and said it was "long overdue". "There has been a meteoric rise in the use of medicinal cannabis, and that is clear from all the data from the state and federal levels," he told The Senior. "The seniors' market is one of the fastest growing sectors for the medicinal cannabis industry, because of its ability to help with pain, arthritis, stress and sleep management." Read more from The Senior: Mr Ettershank said it's been a "Godsend" to be able to be prescribed approved medicinal cannabis to treat his auto-immune condition Polymyalgia Rheumatica, and ongoing chronic back pain from an injury, though admits it's not a "miracle cure for all ailments". The Senior understands only two medicinal cannabis products have been approved by the TGA, meaning many other products are accessed through the unapproved goods scheme. "Telehealth is an important mechanism to improve access to health services - but these direct-to-consumer, single-issue models lack clear referral pathways or a feedback loop to GPs and as the TGA has acknowledged, this requires much broader consideration by government," said AMA President Dr Danielle McMullen. "We are seeing increasing reports of patient harm from cannabis, including psychosis, so this current surge in prescriptions is highly concerning ...Clearly, the health landscape has changed dramatically in Australia, so it is vital we look at our regulatory settings and find out what needs to be done to address any gaps." Product-specific telehealth services are one of three key issues raised by the TGA. Other key issues include the safety risks of the products and whether there are appropriate regulations oversight of unapproved medicinal cannabis products being accessed via the Special Access Scheme and Authorised Prescriber Scheme. Like every industry, Mr Ettershank said, there will always be people who do the wrong thing for greed or act improperly, though from his own experience he has found practitioners take their responsibilities very seriously. "It's a relatively new industry, having only been around for 10 years, and it is appropriate that we pause occasionally to reflect on what is happening," he said. "I'm concerned that the scope of their consultation is limited, and it is not an inquiry by multiple agencies .... I'd like to see a holistic approach to regulation, reform, safety and quality in the medicinal cannabis sector, but we look forward to participating in the consultation." Further details on the consultation can be found at For enquiries relating to this public consultation, please email MedicinalCannabisReforms@ The closing date for this consultation is 23.59 AEST on October 7 2025. All submissions received by the deadline, will be considered by the TGA. Cowboy doctors have been put on notice, as telehealth services prescribing unapproved medicinal cannabis to seniors and other vulnerable Australians come under the microscope. Experts have welcomed a move by the government's Therapeutic Goods Administration (TGA) to review the safety and regulatory framework for medicinal cannabis products after increasing public and professional concern. The Australian Medical Association (AMA) said cannabis products are being prescribed at "alarming rates through direct-to-consumer telehealth models". Victorian MP and user of medicinal cannabis, David Ettershank, welcomed the review which includes a callout for public comment, and said it was "long overdue". "There has been a meteoric rise in the use of medicinal cannabis, and that is clear from all the data from the state and federal levels," he told The Senior. "The seniors' market is one of the fastest growing sectors for the medicinal cannabis industry, because of its ability to help with pain, arthritis, stress and sleep management." Read more from The Senior: Mr Ettershank said it's been a "Godsend" to be able to be prescribed approved medicinal cannabis to treat his auto-immune condition Polymyalgia Rheumatica, and ongoing chronic back pain from an injury, though admits it's not a "miracle cure for all ailments". The Senior understands only two medicinal cannabis products have been approved by the TGA, meaning many other products are accessed through the unapproved goods scheme. "Telehealth is an important mechanism to improve access to health services - but these direct-to-consumer, single-issue models lack clear referral pathways or a feedback loop to GPs and as the TGA has acknowledged, this requires much broader consideration by government," said AMA President Dr Danielle McMullen. "We are seeing increasing reports of patient harm from cannabis, including psychosis, so this current surge in prescriptions is highly concerning ...Clearly, the health landscape has changed dramatically in Australia, so it is vital we look at our regulatory settings and find out what needs to be done to address any gaps." Product-specific telehealth services are one of three key issues raised by the TGA. Other key issues include the safety risks of the products and whether there are appropriate regulations oversight of unapproved medicinal cannabis products being accessed via the Special Access Scheme and Authorised Prescriber Scheme. Like every industry, Mr Ettershank said, there will always be people who do the wrong thing for greed or act improperly, though from his own experience he has found practitioners take their responsibilities very seriously. "It's a relatively new industry, having only been around for 10 years, and it is appropriate that we pause occasionally to reflect on what is happening," he said. "I'm concerned that the scope of their consultation is limited, and it is not an inquiry by multiple agencies .... I'd like to see a holistic approach to regulation, reform, safety and quality in the medicinal cannabis sector, but we look forward to participating in the consultation." Further details on the consultation can be found at For enquiries relating to this public consultation, please email MedicinalCannabisReforms@ The closing date for this consultation is 23.59 AEST on October 7 2025. All submissions received by the deadline, will be considered by the TGA. Cowboy doctors have been put on notice, as telehealth services prescribing unapproved medicinal cannabis to seniors and other vulnerable Australians come under the microscope. Experts have welcomed a move by the government's Therapeutic Goods Administration (TGA) to review the safety and regulatory framework for medicinal cannabis products after increasing public and professional concern. The Australian Medical Association (AMA) said cannabis products are being prescribed at "alarming rates through direct-to-consumer telehealth models". Victorian MP and user of medicinal cannabis, David Ettershank, welcomed the review which includes a callout for public comment, and said it was "long overdue". "There has been a meteoric rise in the use of medicinal cannabis, and that is clear from all the data from the state and federal levels," he told The Senior. "The seniors' market is one of the fastest growing sectors for the medicinal cannabis industry, because of its ability to help with pain, arthritis, stress and sleep management." Read more from The Senior: Mr Ettershank said it's been a "Godsend" to be able to be prescribed approved medicinal cannabis to treat his auto-immune condition Polymyalgia Rheumatica, and ongoing chronic back pain from an injury, though admits it's not a "miracle cure for all ailments". The Senior understands only two medicinal cannabis products have been approved by the TGA, meaning many other products are accessed through the unapproved goods scheme. "Telehealth is an important mechanism to improve access to health services - but these direct-to-consumer, single-issue models lack clear referral pathways or a feedback loop to GPs and as the TGA has acknowledged, this requires much broader consideration by government," said AMA President Dr Danielle McMullen. "We are seeing increasing reports of patient harm from cannabis, including psychosis, so this current surge in prescriptions is highly concerning ...Clearly, the health landscape has changed dramatically in Australia, so it is vital we look at our regulatory settings and find out what needs to be done to address any gaps." Product-specific telehealth services are one of three key issues raised by the TGA. Other key issues include the safety risks of the products and whether there are appropriate regulations oversight of unapproved medicinal cannabis products being accessed via the Special Access Scheme and Authorised Prescriber Scheme. Like every industry, Mr Ettershank said, there will always be people who do the wrong thing for greed or act improperly, though from his own experience he has found practitioners take their responsibilities very seriously. "It's a relatively new industry, having only been around for 10 years, and it is appropriate that we pause occasionally to reflect on what is happening," he said. "I'm concerned that the scope of their consultation is limited, and it is not an inquiry by multiple agencies .... I'd like to see a holistic approach to regulation, reform, safety and quality in the medicinal cannabis sector, but we look forward to participating in the consultation." Further details on the consultation can be found at For enquiries relating to this public consultation, please email MedicinalCannabisReforms@ The closing date for this consultation is 23.59 AEST on October 7 2025. All submissions received by the deadline, will be considered by the TGA.
